Skip to main content
. Author manuscript; available in PMC: 2021 Jan 9.
Published in final edited form as: J Health Care Poor Underserved. 2020;31(4):1669–1692. doi: 10.1353/hpu.2020.0126

Table 4.

Regression analysis of ideal cardiovascular health score

Model 1 Model 2 Model 3
Coef.a SE P Coef.a SE P Coef.a SE P
Demographics
Age at baseline −0.14 0.07 0.067 −0.13 0.07 0.074 −0.11 0.08 0.1766
Years of education 0.03 0.03 0.141 0.05 0.04 0.182 0.06 0.04 0.097
Female (Ref: Male) −0.61 0.17 P<0.001 −0.60 0.17 P<0.001 −0.55 0.17 0.002
Racial/ethnic minority (Ref: Non-Hispanic white) −0.52 0.22 0.017 −0.54 0.22 0.014 −0.63 0.23 0.006
Mental Health
Depression (Ref: No) 0.26 0.21 0.219 0.30 0.22 0.163
Schizophrenia/Schizoaffective Disorder (Ref: No) 0.11 0.19 0.571 0.17 0.19 0.390
Substance Abuse or Dependence (Ref: No) −0.20 0.18 0.270 −0.30 0.18 0.090
1st Generation Antipsychotic (Ref: No) −0.76 0.31 0.014 −0.89 0.31 0.004
2nd Generation Antipsychotic (Ref: No)b −0.42 0.20 0.033 −0.51 0.20 0.011
Physical Health
High Cholesterol (Ref: No) −0.09 0.19 0.622
Diabetes (Ref: No) 0.15 0.21 0.473
Cancer (Ref: No) 1.05 0.45 0.019
CRF (6MWT, 50m increase)c 0.12 0.04 0.009
Analytic N 303 299 292
R2 0.072 0.107 0.149
R2 change 0.035* 0.042*
F Statistic 5.74** 3.83** 3.73**
a

Notes: Calculated using ordinary least squares regression.

b

2nd generation includes participants taking only second generation/atypical antipsychotics and those taking both a first- and second-generation antipsychotic.

c

Cardiorespiratory fitness (six-minute walk test).

*

p<0.05;

**

p<0.001